Docetaxel-loaded composite nanoparticles formed by a temperature-induced phase transition for cancer therapy

Journal of Bioactive and Compatible Polymers

Volumn 27, Issue 5, 2012, Pages 441-452

  Yuk, Soon H ^a   Oh, Keun S ^b   Park, Jinah ^a   Lee, Eun H ^a   Kim, Kwangmeyung ^b   Kwon, Ick C ^b  

^a Korea University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

antitumor efficacy; cancer therapy; Composite nanoparticles; docetaxel; in vivo biodistribution; Tween 80 soybean oil

Indexed keywords

ANTI-TUMOR EFFICACY; CANCER THERAPY; COMPOSITE NANOPARTICLES; DOCETAXEL; IN-VIVO; TWEEN 80/SOYBEAN OIL;

COMPOSITE MATERIALS; DEGRADATION; LIQUIDS; OILSEEDS; ONCOLOGY; TUMORS;

DRUG PRODUCTS;

DOCETAXEL; NANOPARTICLE; POLOXAMER; POLYSORBATE 80; SOYBEAN OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EXCRETION; LOW TEMPERATURE; MALE; MOUSE; NONHUMAN; PHASE TRANSITION; TUMOR; TUMOR GROWTH;

ANIMALIA; GLYCINE MAX; MUS;

EID: 84866365760     PISSN: 08839115     EISSN: 15308030     Source Type: Journal    
DOI: 10.1177/0883911512448752     Document Type: Article

References (26)

1. Wu Z, Li B, Jin Q, et al. Phase behavior of binary blends of diblock copolymers. J Phys Chem B. 2010 ; 114: 15789-15798
2. Gan Y-C, Yuan J-F, Liu X-J, et al. ABC triblock copolymers with pH-responsive LCST for controlled drug delivery. J Bioact Compat Polym. 2011 ; 26: 173-190
3. Zou J, Hew CC, Themistou E, et al. Clicking well-defined biodegradable nanoparticles and nanocapsules by UV-induced thiolene cross-linking in transparent miniemulsions. Adv Mater. 2011 ; 69: 45-54
4. Ghoorchian A, Holland NB. Molecular architecture influences the thermally induced aggregation behavior of elastin-like polypeptides. Biomacromolecules. 2011 ; 12: 4022-4029
5. Wang H, Sun S, Wu P. Thermodynamics of hyperbranched poly(ethylenimine) with isobutyramide residues during phase transition: an insight into the molecular mechanism. J Phys Chem B. 2011 ; 115: 8832-8844
6. Deng W, Yamaguchi H, Takashima Y, et al. A chemical-responsive supramolecular hydrogel from modified cyclodextrins. Angew Chem Int Ed. 2007 ; 46: 5144-5147 (Pubitemid 47051275)
7. Jassen H-K, Stenull O. Collapse transition of randomly branched polymers: renormalized field theory. Phys Rev E. 2011 ; 83: 051126-1-051126-21
8. Tanaka F, Koga T, Kaneda I, et al. Hydration, phase separation and nonlinear rheology of temperature-sensitive water-soluble polymers. J Phys Condens Matter. 2011 ; 23: 284105-1-284105-7
9. Lee KE, Kim BK, Yuk SH. Biodegradable polymeric nanospheres formed by temperature-induced phase transition in a mixture of poly(lactide-co-glycolide) and poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer. Biomacromolecules. 2002 ; 3: 1115-1119
10. Oh KS, Song JY, Cho SH, et al. Paclitaxel-loaded pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy. J Control Release. 2010 ; 148: 344-350
11. MacConnachie AM. Docetaxel (Taxotere, Rhone-Poulenc Rorer). Intens Crit Care Nurs. 1997 ; 13: 119-120
12. Kintzel PE, Michaud LB, Lange MK. Docetaxel-associated epiphora. Pharmacotherapy. 2006 ; 26: 853-867 (Pubitemid 43807636)
13. Lavelle F, Bissery MC, Combeau C, et al. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol. 1995 ; 22: 3-16
14. Mu C-F, Balakrishnan P, Cui F-D, et al. The effects of mixed MPEG-PLA/pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials. 2010 ; 31: 2371-2379
15. Yuk SH, Oh KS, Koo H, et al. Multi-core vesicle nanoparticles based on vesicle fusion for delivery of chemotherapic drugs. Biomaterials. 2011 ; 32: 7924-7931
16. Gao K, Sun J, Liu K, et al. Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. Drug Dev Ind Pharm. 2008 ; 34: 1227-1237
17. Abu TMS. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999 ; 88: 1058-1066
18. Hancock BC, Parks M. What is the true solubility advantage for amorphous pharmaceuticals. Pharm Res. 2000 ; 17: 397-404 (Pubitemid 30395293)
19. Zahedi P, Lee PI. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels. Eur J Pharm Biopharm. 2007 ; 65: 320-328
20. Chen D, Jiang X, Huang Y, et al. pH-sensitive mPEG-Hz-cholesterol conjugates as a liposome delivery system. J Bioact Compat Polym. 2010 ; 25 (5). 527-542
21. Ayen WY, Garkhal K, Kumar N. Doxorubicin-loaded (PEG)3-PLA nanopolymersomes: effect of solvents and process parameters on formulation development and in vitro study. Mol Pharm. 2011 ; 8: 466-478
22. Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000 ; 65: 271-284 (Pubitemid 30122932)
23. Dellian M, Yuan F, Trubetskoy VS, et al. Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer. 2000 ; 82: 1513-1518 (Pubitemid 30204355)
24. Harmon AM, Uhrich KE. In vitro evaluation of amphiphilic macromolecular nanocarriers for systemic drug delivery. J Bioact Compat Polym. 2009 ; 24: 185-197
25. Lyer AK, Khaled G, Fang J, et al. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discovery Today. 2006 ; 11: 812-818 (Pubitemid 44280021)
26. Kim JH, Kim YS, Kim S, et al. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release. 2006 ; 111: 228-234 (Pubitemid 43290012)